Masimo (MASI)
(Real Time Quote from BATS)
$136.52 USD
+0.38 (0.28%)
Updated Apr 29, 2024 12:08 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MASI 136.52 +0.38(0.28%)
Will MASI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MASI
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Reasons Why You Should Retain Masimo (MASI) Stock for Now
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Other News for MASI
Buy Rating Affirmed for Masimo Amidst Stable Financials and Strategic Business Optimism
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
Masimo Reaches Analyst Target Price
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Ensemble Fund Q1 2024 Investment Update